Flu Resources

  • Home
  • Flu Resources
NCL Wide

North Central London ICB has an ambitious target of significantly increasing flu vaccination uptake rates in NCL and it values all your efforts in ensuring your at-risk patients are protected against the flu virus this winter.

The ICB has put together some resources that you might find useful to assist you in having the highest possible uptake rates, therefore protecting your patients and increasing your practice income. The payment for administering the vaccination has gone up to £10.06. Public Health England and NHS England expect practices to invite 100% of all eligible patients.

Who should have the flu vaccine?

This year, in addition to targeting all patients in at-risks groups (the over 50s, carers, pregnant women and two-to-four year olds), the vaccination programme will be extended to all secondary school pupils, which means that all school-aged children will now be offered the vaccine for the first time in England.

There remains a need to focus on immunising two and three year olds and also ensuring that all practice staff have the vaccine. Where practice staff are immunised in other settings, it is important that this information is included in the ImmForm submissions to reflect how many primary care staff have been vaccinated.

NCL ICB will be working with local authorities and other partners to support the national winter vaccinations campaign, highlighting the key messages around the importance of flu vaccinations and Covid-19 boosters for at-risk groups and promoting general advice for staying well over the winter months.

The flu programme is a coordinated and evidence-based approach to planning for the demands of flu across England.

Each year the NHS prepares for the unpredictability of flu. For most healthy people, flu is an unpleasant but usually self-limiting disease with recovery generally within a week. However, there is a particular risk of severe illness from catching flu for:

  • older people
  • the very young
  • pregnant women
  • those with underlying disease, particularly chronic respiratory or cardiac disease
  • those who are immunosuppressed

Review date: Monday, 31 October 2022